Solid Biosciences (SLDB) Total Current Liabilities (2017 - 2024)
Historic Total Current Liabilities for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $22.9 million.
- Solid Biosciences' Total Current Liabilities rose 4449.92% to $22.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $22.9 million, marking a year-over-year increase of 4449.92%. This contributed to the annual value of $14.5 million for FY2023, which is 3550.29% down from last year.
- As of Q3 2024, Solid Biosciences' Total Current Liabilities stood at $22.9 million, which was up 4449.92% from $14.7 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Total Current Liabilities ranged from a high of $24.5 million in Q4 2020 and a low of $12.9 million during Q1 2020
- For the 5-year period, Solid Biosciences' Total Current Liabilities averaged around $18.8 million, with its median value being $20.3 million (2023).
- Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 7724.38% in 2021, then tumbled by 3550.29% in 2023.
- Over the past 5 years, Solid Biosciences' Total Current Liabilities (Quarter) stood at $24.5 million in 2020, then fell by 3.59% to $23.6 million in 2021, then fell by 4.63% to $22.5 million in 2022, then tumbled by 35.5% to $14.5 million in 2023, then soared by 57.43% to $22.9 million in 2024.
- Its last three reported values are $22.9 million in Q3 2024, $14.7 million for Q2 2024, and $14.3 million during Q1 2024.